Categories Uncategorized

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) to Benefit as Countries Seek Natural Options for Crops Protection

  • Demand for food increasing as world population swells; pesticides paramount to maintain supply
  • Countries banning pesticides deemed hazardous, but alternatives are lacking
  • MustGrow is solution provider for global food supply with its natural biological crop protection for high-value crops

As the world population is increasing at an accelerated pace, a stable food supply is becoming critical to ensure food availability across the world. MustGrow (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) is playing a key role in providing biotechnology that secures both steady and high-quality crop supply.

To ensure a consistent flow of produce, crops need protection. For that, producers have been using various synthetic pesticides, which have become irreplaceable in creating a stable and abundant food supply for the global population. Indispensable for controlling weeds, pests and plant pathogens that threaten crops, synthetic pesticides contribute to higher yields and improved quality.

Still, not all of pesticides are created equal; some have even been deemed hazardous by the World Health Organization (“WHO”). Some pesticides on that hazardous list are still being used around the world, including in the United States. A recent article cites that around 150 agricultural pesticides considered hazardous to human health by WHO were used in the United States within the last few years (https://ibn.fm/wVmJt).

Although using potentially risky compounds has been an accepted part of the global food industry, the pressure to move away from that is growing. Both industry and governments are increasingly recognizing the importance of natural products to secure a quality food supply for the world while keeping health and safety in mind.

Although some jurisdictions are more advanced in scrutinizing the use of chemical pesticides in human consumption at present — resulting in some of those substances being banned — with globally integrated food supply chains, the world will likely see the convergence of these regulations on the international scale. As this happens, natural alternatives to chemical pesticides will become paramount to ensure a steady stream of crops while also adhering to strict health and safety standards (https://ibn.fm/3kU0S).

As bans on certain chemical pesticides continue to spread, natural alternatives are needed to fill this gap and secure the global food supply. To transition effectively away from chemical pesticides, new “biological” products need to have not only a safer and more eco-conscious profile but comparable efficacy and pricing as well. This is where MustGrow steps in.

As an agriculture biotech company committed to creating natural biological crop protection for high-value crops, MustGrow positions itself as a critical part of the food ecosystem of the future. The company has developed EPA-approved biotechnology that uses the mustard seed’s natural defense mechanism to protect plants from pests and diseases, offering a natural solution as an increasing number of markets seek natural alternatives for chemical pesticides.

Focused on developing breakthroughs in agriculture to enable farmers to use natural, safe and efficient products, MustGrow is a part of the solution to the global food supply problem with its unique, natural and organic product. As the market gap widens, MustGrow’s solution is showing comparable efficacy, consistency and potentially price compared to traditional synthetic chemicals, opening a global opportunity for the pioneering company to leverage the rising demand and help maintain both stable and high-quality food supply.

For more information, visit the company’s website at www.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at https://ibn.fm/MGROF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Committed to Advancing Cancer Care with Innovative RTNova Platform Research

Cancer statistics underscore the urgency of ongoing cancer research and the need for more effective…

33 minutes ago

AI Can Predict the Recurrence of Brain Tumors in Kids, Study Finds

A team of researchers has leveraged a technique called temporal learning to train an AI…

1 hour ago

Nutriband Inc. (NASDAQ: NTRB) Leadership Team: Driving Innovation and Shaping the Future of Global Healthcare

Sheridan was recently named as a finalist for the 2025 EY Entrepreneur of the Year…

1 hour ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Reports Innovative RTNova Platform Research, Exemplifies Pivotal Role of Research

“Research on the treatment of cancer is fundamental to improving outcomes for all patients affected…

1 day ago

Adageis Offering Comprehensive Healthcare AI Tools to Support Profitable Shift to Value-Based Care

Adageis offers an AI-powered financial technology platform tailored to healthcare providers seeking a financially positive…

5 days ago

Scientists ID Bacteria That Could Be Behind Multiple Sclerosis Development

A new study focusing on twins has found that individuals with a larger presence of…

5 days ago